163 related articles for article (PubMed ID: 3921760)
1. Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome.
Govaerts L; Bakkeren J; Monnens L; Maas J; Trijbels F; Kleijer W
J Inherit Metab Dis; 1985; 8(1):5-8. PubMed ID: 3921760
[TBL] [Abstract][Full Text] [Related]
2. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
3. Serum very long chain fatty acid pattern in Zellweger syndrome.
Bakkeren JA; Monnens LA; Trijbels JM; Maas JM
Clin Chim Acta; 1984 Apr; 138(3):325-31. PubMed ID: 6723067
[TBL] [Abstract][Full Text] [Related]
4. A sibship with a mild variant of Zellweger syndrome.
Barth PG; Schutgens RB; Wanders RJ; Heymans HS; Moser AE; Moser HW; Bleeker-Wagemakers EM; Jansonius-Schultheiss K; Derix M; Nelck GF
J Inherit Metab Dis; 1987; 10(3):253-9. PubMed ID: 3123783
[TBL] [Abstract][Full Text] [Related]
5. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
7. Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts.
Singh H; Derwas N; Poulos A
Arch Biochem Biophys; 1987 May; 254(2):526-33. PubMed ID: 2437859
[TBL] [Abstract][Full Text] [Related]
8. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.
Moser AE; Singh I; Brown FR; Solish GI; Kelley RI; Benke PJ; Moser HW
N Engl J Med; 1984 May; 310(18):1141-6. PubMed ID: 6709009
[TBL] [Abstract][Full Text] [Related]
9. [Zellweger's syndrome (cerebro-hepato-renal syndrome)--its clinical picture, morphology and biochemical diagnosis].
Koch M; Wolf H
Klin Padiatr; 1985; 197(6):492-7. PubMed ID: 4087827
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of Zellweger's cerebrohepatorenal syndrome].
Schutgens RB; Heymans HS; Purvis R; Wanders RJ; Schrakamp G; van den Bosch H
Tijdschr Kindergeneeskd; 1984 Dec; 52(6):231-8. PubMed ID: 6528320
[TBL] [Abstract][Full Text] [Related]
11. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
12. Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal-onset adrenoleukodystrophy.
Black VH; Cornacchia L
Am J Anat; 1986 Sep; 177(1):107-18. PubMed ID: 3776884
[TBL] [Abstract][Full Text] [Related]
13. Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.
Schutgens RB; Wanders RJ; Heymans HS; Schram AW; Tager JM; Schrakamp G; van den Bosch H
J Inherit Metab Dis; 1987; 10 Suppl 1():33-45. PubMed ID: 3119940
[TBL] [Abstract][Full Text] [Related]
14. The cerebro-hepato-renal (Zellweger) syndrome: prenatal detection based on impaired biosynthesis of plasmalogens.
Schutgens RB; Schrakamp G; Wanders RJ; Heymans HS; Moser HW; Moser AE; Tager JM; Bosch HV; Aubourg P
Prenat Diagn; 1985; 5(5):337-44. PubMed ID: 4070172
[TBL] [Abstract][Full Text] [Related]
15. The cerebro-hepato-renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts.
Schrakamp G; Schutgens RB; Wanders RJ; Heymans HS; Tager JM; Van den Bosch H
Biochim Biophys Acta; 1985 Jan; 833(1):170-4. PubMed ID: 3967038
[TBL] [Abstract][Full Text] [Related]
16. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.
Brown FR; McAdams AJ; Cummins JW; Konkol R; Singh I; Moser AB; Moser HW
Johns Hopkins Med J; 1982 Dec; 151(6):344-51. PubMed ID: 7176294
[No Abstract] [Full Text] [Related]
17. Very long chain fatty acids in genetic peroxisomal disease fibroblasts: differences between the cerebro-hepato-renal (Zellweger) syndrome and adrenoleukodystrophy variants.
Molzer B; Korschinsky M; Bernheimer H; Schmid R; Wolf C; Roscher A
Clin Chim Acta; 1986 Nov; 161(1):81-90. PubMed ID: 3815856
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26:0) beta-oxidation in cultured chorionic villous fibroblasts: implications for early diagnosis of other peroxisomal disorders.
Wanders RJ; van Wijland MJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM; Nijenhuis A; Tromp A
Clin Chim Acta; 1987 Jun; 165(2-3):303-10. PubMed ID: 3652452
[TBL] [Abstract][Full Text] [Related]
19. Physiological significance of fatty acid elongation system in adrenoleukodystrophy.
Koike R; Tsuji S; Ohno T; Suzuki Y; Orii T; Miyatake T
J Neurol Sci; 1991 Jun; 103(2):188-94. PubMed ID: 1880537
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts.
Poulos A; Usher S; Paton BC
Lipids; 1993 Feb; 28(2):97-102. PubMed ID: 8441343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
